The New Torrent
The 'pharmaceutical to power' group has kickstarted a makeover plan with focus on renewable and diversification into health.
pharmaceuticals sector
November 2024
September 2024
AstraZeneca Pharma gets nod to sell immunotherapy drug Durvalumab; stock surges
This surge came after the company announced approval to import and distribute Durvalumab (Imfinzi) infusion in two dosages.
